PRACTICE-ORIENTED PRAGMATIC TRIALS CAN INTEGRATE INNOVATIONS MORE RAPIDLY IN EVIDENCE-BASED MEDICINE
June 1, 2021
Learn on pragmatic randomized clinical trials and real-world evidence
- Patient access to evidence-based innovations can be accelerated if practice-oriented trials are timely conducted.
- Such trials have patient relevant outcomes, recruit a broad patient population and have usual care as comparator.
- Facilitators would be an alignment of the evidentiary requirements of regulators and HTA/payers as well as a framework for an efficient conduct of trials based on coded electronic health records.
WATCH RECORDED WEBINAR
Frank Hulstaert, MD, MSc, FBCPM
Senior Researcher Belgian Health Care Knowledge Centre
Frank Hulstaert studied medicine in Ghent (MD, 1985), informatics in Brussels (MSc) and biostatistics at Hasselt University, Belgium. He started a residency in internal medicine but soon turned to industry, where he worked at Applied Artificial Intelligence, IBM, Becton and Dickinson, Sandoz/Novartis and Innogenetics. He was mainly involved in the development of in vitro diagnostics, pharmaceuticals and biopharmaceuticals, as medical expert and later as medical director. He joined the Belgian Health Care Knowledge Centre (KCE) in 2004 as a senior researcher. He was mainly involved in health technology assessments and since 2016 also in KCE Trials, a program of publicly funded practice-oriented trials.